TFX vs UFPT
TFX: Teleflex provides essential, specialty medical technologies used in critical care and surgical procedures to improve patient outcomes. UFPT: UFP Technologies is a custom-engineered component manufacturer providing specialized solutions primarily for the medical device and healthcare industries.
Side-by-side fundamentals
| Metric | TFX | UFPT | Edge |
|---|---|---|---|
| Price as of 2026-08-24 close | $138.31 | $309.13 | |
| Market cap as of 2026-08-24 | $5.9B | $2.4B | |
| P/E as of 2026-08-24 | n/a | 34.94 | |
| PEG as of 2026-08-24 | 0.74 | 4.35 | TFX lower |
| Net margin as of 2026-08-24 | -39.7% | +11.4% | UFPT higher |
| Gross margin as of 2026-08-24 | +53.8% | +28.5% | TFX higher |
| Operating margin as of 2026-08-24 | -11.7% | +15.3% | UFPT higher |
| ROE as of 2026-08-24 | -31.9% | +16.7% | UFPT higher |
| ROA as of 2026-08-24 | -14.5% | +10.8% | UFPT higher |
| Debt / equity as of 2026-08-24 | 0.97 | 0.25 | UFPT lower |
| Revenue growth (YoY) as of 2026-08-24 | -14.5% | +7.3% | UFPT higher |
| Revenue CAGR (3y) SEC XBRL | -10.6% | +22.7% | UFPT higher |
| Dividend yield as of 2026-08-24 | +0.6% | n/a | |
| Dividend streak (yrs) SEC XBRL | 5 | n/a | |
| Beta as of 2026-08-24 | 0.74 | 1.05 | |
| 1-year return as of 2026-08-24 close | +6.9% | +40.8% | UFPT higher |
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-24.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.